Does NIRSEVIMAB-ALIP Cause Respiratory syncytial virus bronchiolitis? 135 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 135 reports of Respiratory syncytial virus bronchiolitis have been filed in association with NIRSEVIMAB-ALIP. This represents 17.2% of all adverse event reports for NIRSEVIMAB-ALIP.
135
Reports of Respiratory syncytial virus bronchiolitis with NIRSEVIMAB-ALIP
17.2%
of all NIRSEVIMAB-ALIP reports
1
Deaths
72
Hospitalizations
How Dangerous Is Respiratory syncytial virus bronchiolitis From NIRSEVIMAB-ALIP?
Of the 135 reports, 1 (0.7%) resulted in death, 72 (53.3%) required hospitalization, and 13 (9.6%) were considered life-threatening.
Is Respiratory syncytial virus bronchiolitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIRSEVIMAB-ALIP. However, 135 reports have been filed with the FAERS database.
What Other Side Effects Does NIRSEVIMAB-ALIP Cause?
Drug ineffective (173)
Bronchiolitis (83)
Incorrect dose administered (80)
Respiratory syncytial virus infection (76)
Pyrexia (54)
Cough (45)
Respiratory syncytial virus test positive (36)
Extra dose administered (30)
Product storage error (30)
Rash (25)
What Other Drugs Cause Respiratory syncytial virus bronchiolitis?
PALIVIZUMAB (193)
NIRSEVIMAB (87)
ONDANSETRON (17)
SYNAGIS (14)
PREDNISONE (8)
MYCOPHENOLATE MOFETIL (7)
NUSINERSEN (7)
RITUXIMAB (7)
VIGABATRIN (7)
DEXAMETHASONE (6)
Which NIRSEVIMAB-ALIP Alternatives Have Lower Respiratory syncytial virus bronchiolitis Risk?
NIRSEVIMAB-ALIP vs NITAZOXANIDE
NIRSEVIMAB-ALIP vs NITISINONE
NIRSEVIMAB-ALIP vs NITRAZEPAM
NIRSEVIMAB-ALIP vs NITRENDIPINE
NIRSEVIMAB-ALIP vs NITRIC